Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Paracetamol/Pembrolizumab

Stevens-Johnson-syndrome and erythema multiforme-like rash

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tanaka N, et al. Erythema multiforme associated with cancer radiotherapy: A single-institution case series and literature review. Journal of Dermatology 50: 656-663, No. 5, May 2023. Available from: URL: 10.1111/1346-8138.16695 Tanaka N, et al. Erythema multiforme associated with cancer radiotherapy: A single-institution case series and literature review. Journal of Dermatology 50: 656-663, No. 5, May 2023. Available from: URL: 10.1111/1346-8138.16695
Metadaten
Titel
Paracetamol/Pembrolizumab
Stevens-Johnson-syndrome and erythema multiforme-like rash
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55317-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Ocrelizumab